Description

Epithalon (Epitalon; Tetrapeptide Ala-Glu-Asp-Gly)

Description

• Epithalon is a synthetic tetrapeptide (Ala‑Glu‑Asp‑Gly) derived from epithalamin, studied for its potential role in regulating cellular aging processes and circadian function.
• Investigational compound researched for effects on telomere maintenance, cell-cycle regulation, and longevity‑related biomarkers.

Key benefits (research findings)

• Shown in preclinical and limited clinical studies to influence telomerase activity and support telomere maintenance in some cell types.
• Associated in animal models with improved markers of cellular resilience, antioxidant status, and age‑related functional outcomes.
• Investigated for potential benefits on sleep regulation and circadian rhythm normalization in select studies.
• Useful as a research tool to probe mechanisms of aging, senescence, and regenerative signaling.

Primary uses

• Preclinical and translational research into aging biology, telomere dynamics, and interventions targeting cellular senescence.
• Early‑phase human research under controlled clinical protocols exploring biomarkers of aging and functional endpoints.

Suggested use (research context)

• Administer per validated study protocols; routes in research include parenteral administration (e.g., subcutaneous or intramuscular) with dosing and schedules defined by investigators.
• Establish dose‑finding, safety monitoring, and appropriate controls in pilot studies before broader application.

Safety and storage

• Human safety and long‑term effects are not fully established; avoid unsupervised use outside approved research or clinical settings.
• Possible risks and adverse effects remain incompletely characterized—monitor subjects for unexpected events and standard clinical safety parameters.
• Handle with laboratory PPE and aseptic technique. Store lyophilized peptide per supplier instructions (commonly refrigerated or frozen); reconstitute and aliquot to minimize freeze–thaw cycles and follow stability data.

Quick facts

• Sequence: Ala‑Glu‑Asp‑Gly (A‑E‑D‑G). Originates from epithalamin, a pineal gland extract studied in gerontology research.
• Mechanism: may modulate telomerase activity, cell‑cycle regulators, and stress‑response pathways—mechanisms remain under investigation.
• Status: investigational; not an approved anti‑aging therapy. Evidence is preliminary and primarily preclinical or from small clinical studies.
• Procurement: available to research labs from peptide suppliers with appropriate institutional approvals.